NCT03596918View on ClinicalTrials.gov

Evaluating Quality of Life in Patients With AIDS-Associated Kaposi Sarcoma Treated With Bleomycin and Vincristine

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

October 10, 2018

Primary Completion Date

June 13, 2020

Study Completion Date

June 13, 2020

Conditions
AIDS-Related Kaposi SarcomaHuman Immunodeficiency Virus 1 Positive
Interventions
BIOLOGICAL

Bleomycin Sulfate

Given IV

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

DRUG

Vincristine Sulfate

Given IV

Trial Locations (1)

Unknown

Bugando Medical Centre, Mwanza

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

The Emmes Company, LLC

INDUSTRY

collaborator

University of Arkansas

OTHER

collaborator

University of California, Los Angeles

OTHER

lead

AIDS Malignancy Consortium

NETWORK

NCT03596918 - Evaluating Quality of Life in Patients With AIDS-Associated Kaposi Sarcoma Treated With Bleomycin and Vincristine | Biotech Hunter | Biotech Hunter